Company Profile (AI Text)
Name: QUANTGENE
Canonical URL: https://wefunder.com/quantgene
Updated at: 2026-06-15T23:52:11Z

Tagline: Ending Cancer with Intelligent Genomics

Key claims:
- Total raised on Wefunder: 0 | citation: https://wefunder.com/quantgene#claim-total-raised
- Total investors: 0 | citation: https://wefunder.com/quantgene#claim-total-investors

Verified facts:
- Total raised on Wefunder: 0 | observed_at: 2026-06-15T23:52:11Z | expires_at: 2026-06-16T23:52:11Z
- Total investors: 0 | observed_at: 2026-06-15T23:52:11Z | expires_at: 2026-06-16T23:52:11Z

Computed metrics:
- total_amount_raised: 0
- total_investors: 0
- team_size: 7
- featured_investor_count: 7
- faq_count: 2
- recent_post_count: 2

Quick facts:
- Realized $50mm in revenue. | citation: https://wefunder.com/quantgene#claim-fact-1
- Combines genomics, AI and medical intelligence technology for universal cancer detection. | citation: https://wefunder.com/quantgene#claim-fact-2
- Pole position to disrupt the $168B cancer diagnostics and early detection market. | citation: https://wefunder.com/quantgene#claim-fact-3
- Invested $36mm into R&D to date. | citation: https://wefunder.com/quantgene#claim-fact-4
- $200mm current deal pipeline with hospital systems. | citation: https://wefunder.com/quantgene#claim-fact-5
- Established distribution partnerships to reach 70,000 customers in 2024 for its Qx solution. | citation: https://wefunder.com/quantgene#claim-fact-6

FAQ:
- Q: Do you have any patents?
  A: Hi Grigore, thanks for supporting our mission!! Yes, we have 4 patents, two specifically covering out liquid biopsy cancer detection technology (genomics + algorithms). However, patents are only a small fraction of the relevant IP we build. The key to our QX system is a comprehensive medical intelligence system that connects genomics, imaging results and other medical data into a full picture of lifetime AND acute cancer risks by organ and coordinates all relevant follow-up diagnostics to ach...
- Q: I’m excited about researching your company as a possible investment and I have several questions. What is your annual income and net profit? Does the company have any debt? Who are your competitors? Based on current sales what are your growth projections for revenue out to 203...
  A: Jude, thank you for your questions! We had $2.5mm revenue in 2023. We are transitioning our commercial product mix from laboratory and pandemic-related to a full focus on cancer this year going forward, which will lead to a decline in 2024 and then a projected exponential growth beginning in 2025. You can see our financial projections on the WeFunder page. Our strategy is focused around large hospital systems who want our turnkey solutions inhouse, both for reimbursed genetic testing and for ...

Recent posts:
- We just partnered with GetLabs for nationwide at-home blood draws for Universal Cancer Detection (2024-01-20T21:36:21Z) https://wefunder.com/feed/170103
- Let's End Cancer in 2024 (2024-01-02T21:09:29Z) https://wefunder.com/feed/169759